Platelets can interact with cancer cells causing phenotypic changes in cancer cells, including the induction of epithelial-mesenchymal transition (EMT)-related gene expression and the cyclooxygenase (COX)-2-signaling pathway [5,6]. Here, PTGS2 is linked to cancer.